# Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC

> **NCT04912882** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 1000 (estimated)

## Conditions studied

- Colorectal Cancer
- Circulating Tumor Cell

## Interventions

- **DIAGNOSTIC_TEST:** Circulating tumor cell

## Key facts

- **NCT ID:** NCT04912882
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-15
- **Primary completion:** 2023-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912882, "Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04912882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*